Health diplomacy in action: the cancer legacy of the Good Friday Agreement

Mark Lawler*, Richard Sullivan, Ghassan K. Abou-Alfa, Karen McCloskey, Debbie Keatley, Jennifer Feighan, William Dahut, Eibhlin Mulroe, Robert Ladner, Mohamed Genead, Maeve Lowery, James L. Gulley, Christopher J. Scott, Daniel B. Longley, Aedin Culhane, William M. Gallagher, Nick Orr, Stephen J. Chanock, Satish Gopal

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Downloads (Pure)


2023 marks the 25th anniversary of the Good Friday Agreement, which led peace in Northern Ireland. As well as its impact on peace and reconciliation, the Good Friday Agreement has also had a lasting positive impact on cancer research and cancer care across the island of Ireland. Pursuant to the Good Friday Agreement, a Memorandum of Understanding (MOU) was signed between the respective Departments of Health in Ireland, Northern Ireland and the US National Cancer Institute (NCI), giving rise to the Ireland – Northern Ireland – National Cancer Institute Cancer Consortium, an unparalleled tripartite agreement designed to nurture and develop linkages between cancer researchers, physicians and allied healthcare professionals across Ireland, Northern Ireland and the US, delivering world class research and better care for cancer patients on the island of Ireland and driving research and innovation in the US.

Original languageEnglish
Article number100448
Number of pages3
JournalJournal of Cancer Policy
Early online date20 Oct 2023
Publication statusPublished - Dec 2023


Dive into the research topics of 'Health diplomacy in action: the cancer legacy of the Good Friday Agreement'. Together they form a unique fingerprint.

Cite this